Meridian Launches its Novel Air-Dryable RT-qPCR Mix, Further Decreases Costs and Simplifies Workflows for COVID-19 Molecular ...
December 03 2020 - 10:00AM
Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider
of diagnostic testing solutions and life science raw materials,
announced today that it has launched an Air-Dryable RT-qPCR Mix,
driving innovation in the development of molecular tests with
ambient temperature stability. This specialized master mix is
designed for air-drying, a cost-effective and easier alternative to
lyophilization. With this new product addition, Meridian has the
most comprehensive offering of master mixes for developing both DNA
and RNA based molecular diagnostic assays at ambient temperature,
removing the need for cold chain shipping and storage.
While molecular diagnostic tests are
progressively moving towards a dried-down format, there are
technical challenges in developing lyophilization-compatible mixes
that require lengthy optimization and expensive lyophilization
equipment. Building on its expertise in qPCR chemistries, the Life
Science division of Meridian Bioscience has successfully developed
a ready-to-use, air-dryable RT-qPCR mix to meet the growing demand
within the molecular diagnostics industry for an easier and more
cost-effective method of drying RNA assays.
Meridian’s Air-Dryable RT-qPCR Mix has been
designed to simplify development, manufacturing and storage of
molecular assays while delivering fast detection of RNA targets, an
ideal solution for COVID-19 assay development. Its one-tube format
chemistry containing all reagents necessary for a RT-qPCR,
including magnesium, dNTP and reverse transcriptase, not only
shortens assay optimization but is also compatible with air-drying
protocols. This new mix shows exceptionally high performance in
both singleplex and multiplex reactions following rehydration,
making it ideally suited for a wide range of instruments from
automated high-throughput platforms to point-of-care devices.
Florent Chang-Pi-Hin, PhD, Senior Director of
Research and Development added, “Over the last 12 months, we have
seen a significant increase in demand for our Lyo-Ready RT-qPCR
mixes; however, not all our customers have the expertise in-house
to lyophilize. Building on the launch of our Air-Dryable qPCR Mix
earlier this year, our new Air-Dryable RT-qPCR Mix represents a
perfect solution for the development of ambient temperature stable
assays for RNA targets, which is so important today with the global
fight against SARS-CoV-2.”
Meridian is committed to suppling innovative
solutions to the diagnostic industry to simplify and accelerate
development of superior diagnostic assays. For more information on
partnering with Meridian Bioscience, please visit
meridianlifescience.com or email
lourdes.weltzien@meridianlifescience.com.
About Meridian Bioscience,
Inc.Meridian is a fully integrated life science company
that develops, manufactures, markets and distributes a broad range
of innovative diagnostic products. We are dedicated to developing
and delivering better solutions that give answers with speed,
accuracy and simplicity that are redefining the possibilities of
life from discovery to diagnosis. Through discovery and
development, we provide critical life science raw materials used in
immunological and molecular tests for human, animal, plant, and
environmental applications. Through diagnosis, we provide
diagnostic solutions in areas including gastrointestinal and upper
respiratory infections and blood lead level testing. We build
relationships and provide solutions to hospitals, reference
laboratories, research centers, veterinary testing centers,
physician offices, diagnostics manufacturers, and biotech companies
in more than 70 countries around the world.
Meridian’s shares are traded on the NASDAQ
Global Select Market, symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact:Charlie WoodVice President – Investor
RelationsMeridian Bioscience, Inc.Phone: +1 513.271.3700Email:
mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Oct 2024 to Nov 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Nov 2023 to Nov 2024